v3.25.1
Net Loss Per Share Attributable to Common Stockholders (Tables)
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Calculation of Basic and Diluted Net Loss Per Share
The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock as of:
Three months ended
March 31,
20252024
(in thousands except
per share amounts)
Numerator:
Net income (loss) from continuing operations
$934 $(16,010)
Loss from discontinued operations, net of income tax
(8,647)(314)
Net loss attributable to common stockholders$(7,713)$(16,324)
Denominator:
Weighted-average shares of common stock outstanding, basic
183,468 186,635 
Weighted-average shares of common stock outstanding, diluted
185,222 186,635 
Net income (loss) per share attributable to common stockholders, basic:
Continuing operations$0.01 $(0.09)
Discontinued operations(0.05)— 
Net loss per share$(0.04)$(0.09)
Net income (loss) per share attributable to common stockholders, diluted:
Continuing operations$0.01 $(0.09)
Discontinued operations(0.05)— 
Net loss per share$(0.04)$(0.09)
The following table illustrates the reconciliation of the denominators of the basic and diluted EPS computations for income (loss) from continuing operations and loss from discontinued operations, net of income tax.
Three months ended
March 31,
20252024
(in thousands)
Weighted-average shares of common stock outstanding, basic
183,468 186,635 
Shares of common stock subject to outstanding RSUs
470 — 
Shares of common stock subject to outstanding options
1,077 — 
Shares of common stock pursuant to ESPP
207 — 
Weighted-average shares of common stock outstanding, diluted
185,222 186,635 
Schedule of Antidilutive Outstanding Common Stock Excluded from Computation of Diluted Net Loss Per Share
The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect as of:
March 31,
20252024
(in thousands)
Outstanding stock options and unvested RSUs
19,612 18,330 
Shares of common stock pursuant to ESPP— 227 
Total anti-dilutive outstanding potential common stock19,612 18,557